Your browser doesn't support javascript.
loading
Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.
Casanova, Alexandre G; Roth, Gael S; Hausmann, Simone; Lu, Xiaoyin; Bischoff, Ludivine J M; Froeliger, Emilie M; Belmudes, Lucid; Bourova-Flin, Ekaterina; Flores, Natasha M; Benitez, Ana Morales; Chasan, Tourkian; Caporicci, Marcello; Vayr, Jessica; Blanchet, Sandrine; Ielasi, Francesco; Rousseaux, Sophie; Hainaut, Pierre; Gozani, Or; Le Romancer, Muriel; Couté, Yohann; Palencia, Andres; Mazur, Pawel K; Reynoird, Nicolas.
Afiliação
  • Casanova AG; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Roth GS; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Hausmann S; Clinique Universitaire d'Hépato-gastroentérologie et Oncologie digestive, CHU Grenoble Alpes, Grenoble, France.
  • Lu X; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bischoff LJM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Froeliger EM; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Belmudes L; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Bourova-Flin E; Grenoble Alpes University, CEA, INSERM, UA13 BGE, CNRS CEA, FR2048, Grenoble, France.
  • Flores NM; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Benitez AM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chasan T; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Caporicci M; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vayr J; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Blanchet S; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Ielasi F; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Rousseaux S; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Hainaut P; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Gozani O; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Le Romancer M; Department of Biology, Stanford University, Stanford, CA, USA.
  • Couté Y; Université de Lyon, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Lyon, France.
  • Palencia A; Grenoble Alpes University, CEA, INSERM, UA13 BGE, CNRS CEA, FR2048, Grenoble, France.
  • Mazur PK; Grenoble Alpes University, CNRS UMR 5309, INSERM U 1209, Institute for Advanced Biosciences, Grenoble, France.
  • Reynoird N; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PKMazur@mdanderson.org.
Cell Discov ; 10(1): 34, 2024 Mar 26.
Article em En | MEDLINE | ID: mdl-38531836

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article